Literature DB >> 10454367

The specific role of cGMP in hippocampal LTP.

H Son1, Y F Lu, M Zhuo, O Arancio, E R Kandel, R D Hawkins.   

Abstract

Previous results have suggested that cGMP is involved in hippocampal long-term potentiation (LTP), perhaps as the presynaptic effector of a retrograde messenger. However, other studies have failed to replicate some of those results, making the role of cGMP uncertain. We therefore reexamined this question and identified several variables that can affect the contribution of cGMP. First, brief perfusion with 8-Br-cGMP before weak tetanic stimulation produced long-lasting potentiation in the CA1 region of hippocampal slices, but more prolonged perfusion with 8-Br-cGMP before the tetanus did not produce long-lasting potentiation. Second, the activity-dependent long-lasting potentiation by cGMP analogs was reduced when NMDA receptors were completely blocked, indicating that NMDA receptor activation contributes to, but is not required for, the potentiation. The amount of reduction of the potentiation differed with different protocols, and in some cases could be complete. Third, LTP produced by strong tetanic stimulation in the stratum radiatum of CA1 (which expresses eNOS) was blocked by inhibitors of soluble guanylyl cyclase or cGMP-dependent protein kinase, but LTP in the stratum oriens (which does not express eNOS) was not. The results of these experiments should help to explain some of the discrepant findings from previous studies, and, in addition, may provide insights into the mechanisms and functional role of the cGMP-dependent component of LTP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10454367      PMCID: PMC313807     

Source DB:  PubMed          Journal:  Learn Mem        ISSN: 1072-0502            Impact factor:   2.460


  34 in total

1.  The role of nitric oxide in hippocampal long-term potentiation.

Authors:  J E Haley; G L Wilcox; P F Chapman
Journal:  Neuron       Date:  1992-02       Impact factor: 17.173

2.  Autoreceptor regulation of glutamate and aspartate release from slices of the hippocampal CA1 area.

Authors:  D Martin; G A Bustos; M A Bowe; S D Bray; J V Nadler
Journal:  J Neurochem       Date:  1991-05       Impact factor: 5.372

3.  NMDA receptor agonists selectively block N-type calcium channels in hippocampal neurons.

Authors:  N I Chernevskaya; A G Obukhov; O A Krishtal
Journal:  Nature       Date:  1991-01-31       Impact factor: 49.962

4.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.

Authors:  J Garthwaite; S L Charles; R Chess-Williams
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

5.  Organization of intrahippocampal projections originating from CA3 pyramidal cells in the rat.

Authors:  N Ishizuka; J Weber; D G Amaral
Journal:  J Comp Neurol       Date:  1990-05-22       Impact factor: 3.215

6.  Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus.

Authors:  J H Williams; M L Errington; M A Lynch; T V Bliss
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

7.  Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger.

Authors:  T J O'Dell; R D Hawkins; E R Kandel; O Arancio
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

8.  7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex.

Authors:  J A Kemp; A C Foster; P D Leeson; T Priestley; R Tridgett; L L Iversen; G N Woodruff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

9.  Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets.

Authors:  J Geiger; C Nolte; E Butt; S O Sage; U Walter
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

10.  Carbon monoxide: a putative neural messenger.

Authors:  A Verma; D J Hirsch; C E Glatt; G V Ronnett; S H Snyder
Journal:  Science       Date:  1993-01-15       Impact factor: 47.728

View more
  37 in total

1.  Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus.

Authors:  Y F Lu; E R Kandel; R D Hawkins
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  Presynaptic role of cGMP-dependent protein kinase during long-lasting potentiation.

Authors:  O Arancio; I Antonova; S Gambaryan; S M Lohmann; J S Wood; D S Lawrence; R D Hawkins
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

3.  Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus.

Authors:  Alain Burette; Ulrike Zabel; Richard J Weinberg; Harald H H W Schmidt; Juli G Valtschanoff
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

4.  Transcriptional analysis in the brain: trophin-induced hippocampal synaptic plasticity.

Authors:  Janet Alder; Smita Thakker-Varia; Ira B Black
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

5.  Disruption of retinogeniculate pattern formation by inhibition of soluble guanylyl cyclase.

Authors:  C A Leamey; C L Ho-Pao; M Sur
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

6.  Persistent changes in spontaneous firing of Purkinje neurons triggered by the nitric oxide signaling cascade.

Authors:  Spencer L Smith; Thomas S Otis
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

7.  A novel role for cyclic guanosine 3',5'monophosphate signaling in synaptic plasticity: a selective suppressor of protein kinase A-dependent forms of long-term potentiation.

Authors:  M Makhinson; P Opazo; H J Carlisle; B Godsil; S G N Grant; T J O'Dell
Journal:  Neuroscience       Date:  2006-03-23       Impact factor: 3.590

Review 8.  Pharmacokinetics and pharmacodynamics of nitric oxide mimetic agents.

Authors:  Austin Horton; Isaac T Schiefer
Journal:  Nitric Oxide       Date:  2019-01-11       Impact factor: 4.427

9.  Improved long-term memory via enhancing cGMP-PKG signaling requires cAMP-PKA signaling.

Authors:  Eva Bollen; Daniela Puzzo; Kris Rutten; Lucia Privitera; Jochen De Vry; Tim Vanmierlo; Gunter Kenis; Agostino Palmeri; Rudi D'Hooge; Detlef Balschun; Harry M W Steinbusch; Arjan Blokland; Jos Prickaerts
Journal:  Neuropsychopharmacology       Date:  2014-05-12       Impact factor: 7.853

10.  Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling.

Authors:  Ottavio V Vitolo; Antonino Sant'Angelo; Vincenzo Costanzo; Fortunato Battaglia; Ottavio Arancio; Michael Shelanski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.